Jiasiteng Pharmaceuticals
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese pharma company developing a mix of small molecules and biologics for the domestic market.
OncologyAutoimmune Diseases
Technology Platform
A hybrid R&D platform encompassing both small molecule discovery and biologics development, including potential biosimilar capabilities.
Opportunities
Significant growth potential by capturing market share in China's vast and growing demand for high-quality pharmaceuticals.
Risk Factors
Exposed to Chinese regulatory changes and intense pricing pressure within the domestic market.
Competitive Landscape
Faces intense competition in China's fragmented pharmaceutical market from numerous local generics/biosimilars firms and innovative biotechs.